TrialFind
Saved trials
Back to results
Unknown
Phase 1
Phase 2
TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery
NCT03881878
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Samsung Medical Center
Seoul, South Korea
Contact
Yeon-hee Park, MD,PhD
2-3410-3459
yeonh.park@samsung.com
View on ClinicalTrials.gov
Official details
TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery — TrialFind